Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  PAIN MANAGEMENT
A Global Strategic Business Report

This report analyzes the worldwide markets for Pain Management in Millions of US$. The specific product segments analyzed are Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 118 companies including many key and niche players worldwide such as AstraZeneca PLC, Elan Corporation PLC, Eli Lilly and Company, Glaxo Smithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer, Inc., Purdue Pharma, Sanofi Aventis, and Wyeth. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1130  PAGES:    319
PRICE:    $3950  DATE:       March 2008
COMPANIES:  118  MARKET DATA TABLES:   102
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  PAIN MANAGEMENT (Complete Report) Pages : 319   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS4$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
CAGR Disparities Between Historic & Current Data.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Pain Management Pharmaceuticals.....I-4
Pain Management Pharmaceuticals.....I-4
Pain Management Services.....I-4
  
II. EXECUTIVE SUMMARY60$2150
  1. Industry Overview.....II-16 $600  
   Pain Management Market to Witness Steady Growth.....II-1
Factors Affecting Pain Management Industry.....II-1
1$100
   Challenges Faced.....II-2
Trends and Issues.....II-2
Generic Drugs Hogs Limelight .....II-2
Cox II Crisis Tarnishes Industry Growth.....II-2
1$100
   Novel Therapies to Propel Opioid and Non- Opioid Therapies.....II-3
Neuropathic Pain - Still an Underserved Market.....II-3
1$100
   Cyclin-dependent kinase 5 (Cdk5).....II-4
Drug Dynamics in the Migraine Market.....II-4
1$100
   Pain Pathways – Gain a Second Look.....II-51$100
   Leading Players.....II-6
Table 1: Leading Players in the Global Pain Management Pharmaceuticals Market (2006): Market Share by Sales for Pfizer, Johnson & Johnson, Novartis, GlaxoSmithkline, and Others (includes corresponding Graph/Chart).....II-6
Status of Major Pipeline Drugs for Pain Management: 2007.....II-6
1$300
  2. Product Overview.....II-721 $1200  
   Pain Management: An Overview.....II-7
Managing Pain.....II-7
What is Pain?.....II-7
Assessment of Pain.....II-7
1$100
   Pain Management.....II-8
Pain Management for Neonates.....II-8
1$100
   Pain Management in Kids.....II-9
Pain Management in Older Adult Surgical Patients.....II-9
1$100
   Pain Therapeutics – An Introduction.....II-10
Treatment of Pain.....II-10
Pharmacologic Method.....II-10
1$100
   Non-pharmacological Method.....II-111$100
   Invasive Procedures.....II-12
Palliative Care.....II-12
1$100
   Alternative Methods.....II-13
Acupuncture.....II-13
Biofeedback.....II-13
Bioelectromagnetic Therapy.....II-13
Biomagnetism and Magnetotherapy.....II-13
1$100
   Guided Imagery.....II-14
Manual/Massage Therapies.....II-14
Aromatherapy Massage.....II-14
Swedish Massage.....II-14
Deep Tissue Massage.....II-14
Neuromuscular Therapy.....II-14
Myofascial Release.....II-14
1$100
   Manual Lymph Drainage.....II-15
Cranial Sacral Therapy.....II-15
Reflexology.....II-15
Naturopathy.....II-15
1$100
   Relaxation Therapy.....II-16
Transcendental Meditation.....II-16
Classification of Pain.....II-16
Acute Pain.....II-16
1$100
   Postoperative pain.....II-17
Labor pain.....II-17
Visceral pain.....II-17
Migraine.....II-17
Treatment of Migraine.....II-17
1$100
   Chronic Pain.....II-18
Cancer pain.....II-18
Back Pain.....II-18
1$100
   Neuropathic Pain.....II-19
Arthritic Pain.....II-19
HIV-Related Pain.....II-19
1$100
   Diabetic Neuropathy.....II-20
Osteo-and Rheumatoid Arthritis Pain.....II-20
1$100
   Pain Management Products and Services.....II-21
Pain Management Pharmaceuticals.....II-21
Nonprescription Drugs.....II-21
Acetaminophen.....II-21
Aspirin.....II-21
Ibuprofen.....II-21
Ketoprofen.....II-21
Naproxen.....II-21
1$100
   Pramoxine.....II-22
Counterirritants.....II-22
Triethanolamine Salicylate (Trolamine).....II-22
Prescription Drugs.....II-22
General Anesthetics.....II-22
Local Anesthetics.....II-22
1$100
   Non-steroidal Anti-Inflammatories (NSAIDs).....II-23
Non-opioid Analgesics.....II-23
Opioid Analgesics.....II-23
2$200
   Pain Management Devices.....II-25
Electrical Spinal Cord Stimulators.....II-25
1$100
   Electrical Stimulus Devices.....II-26
Transcutaneous Electric Nerve Stimulators (TENS).....II-26
Patient-Controlled Analgesia Infusion Devices.....II-26
Pain Management Services.....II-26
Home Care/Providence Home Health.....II-26
Providence Hospices.....II-26
1$100
   Pain Management Centers and Clinics.....II-27
Pain Rehabilitation Programs.....II-27
1$100
  3. Regulatory Environment.....II-282 $200  
   An Overview of Pain Management Regulation.....II-28
OTC Painkillers to Carry Conspicuous Safety Warnings.....II-28
1$100
   Federal Regulatory Norms of Controlled Substances.....II-29
DEA Regulations.....II-29
1$100
  4. Product Innovations/Introductions.....II-303 $300  
   Mallinckrodt Introduces Novel Pain Relieving Agent.....II-30
Shionogi Unveils Cancer Pain Management Drug.....II-30
NeuroTherm Launches RF Generators for Treatment of Heel Pain.....II-30
McNeil Brings Chewable TYLENOL® GoTabs Tablets.....II-30
Barr Unveils Generic Version of ACTIQ®.....II-30
1$100
   Orthofix Unveils e-PainCare.....II-31
Organon Innovates Org 25969.....II-31
Orthofix’s BREG Division Launches Polar Care Motorized Cold Therapy System.....II-31
Zynex Develops New Pain Management Device.....II-31
Eli Lilly and Company Develops Cymbalta.....II-31
1$100
   Pfizer’s Lyrica Gets Nod from the EC.....II-32
New Pain Management Infusion Pumps from Sorenson.....II-32
McKinley Unveils Accufuser Pain Management System.....II-32
1$100
  5. Recent Industry Activity.....II-339 $700  
   Neuromed to Acquire US Rights for Oros Hydromorphone from Alza.....II-33
China Aoxing to Acquire Chinese Pharmaceutical Company, Shijiazhuang Le Ren.....II-33
Vyteris Holdings to Acquire Lehigh Valley Technologies.....II-33
1$100
   Younger America Pockets Life Without Pain.....II-34
PainCare Divests Center for Pain Management.....II-34
Grand Slam Acquires IOMED.....II-34
Ligand Accomplishes Divesture of AVINZA.....II-34
CeNeS and Ergomed Collaborate for Phase II Trials of NMDA Antagonist CNS 5161.....II-34
1$100
   Sorenson Secures Approval to Market Ambulatory Infusion Pump in China.....II-35
PainCare Pockets CPMASC.....II-35
Moog Takes Over Mckinley Medical Corp.....II-35
PainCare Acquires REC, CareFirst Medical Associates.....II-35
1$100
   CLL Pharma Acquires Synt:em.....II-36
AstraZeneca Partners with Pozen to Bring Novel Pain Management Therapy.....II-36
Great Outdoors Acquires Somatic Systems Institute.....II-36
PainCare Partners with Solstice Neurosciences to Offer Pain Management in CD.....II-36
Elan Confers Eisai with European Rights of Prialt.....II-36
Evotec Partners with Apeiron Biologics to Bring Novel Pain Therapy.....II-36
1$100
   Alpaca Enterprises Acquires Neuroscience Therapy Corp.....II-37
PainCare Holdings Acquires Desert Pain Medicine Group......II-37
Wex Pharma Inks Agreement With Boston Children’s Hospital.....II-37
Glenmark Inks Agreement with LVT to Market Pain Management Products.....II-37
EKR Attains North American Marketing Rights for Gelclair.....II-37
Grand Slam Acquires Cefar Medical.....II-37
Omeros Acquires Nura.....II-37
1$100
   Hospira Inks Agreement with Premier.....II-38
Pain Therapeutics Enters into Alliance with King Pharmaceuticals.....II-38
Corgentech Merges with AlgoRx.....II-38
Elder Pharmaceuticals Ventures into the Indian Pain Management Market.....II-38
Xanodyne Acquires Pharmaceutical Assets of aaiPharma.....II-38
1$100
   Pro-Dex Acquires Dental Technology From IntraVantage.....II-39
Encore Medical Acquires Compex Technologies.....II-39
Sosei Acquires Arakis.....II-39
Corgentech Signs Definitive Merger Agreement With AlgoRx.....II-39
Elder Pharmaceuticals Enters into Marketing Agreement with TRB Chemedica.....II-39
1$100
   University Pain Management Center Signs Agreement with Somnia.....II-40
Entelos and Organon to Extend Rheumatoid Arthritis (RA) Collaboration.....II-40
NovaMed Establishes a New Pain Management Center at Indiana.....II-40
Organon and Uriach Collaborate on Developing Kinase Inhibitors.....II-40
1$100
   Toray and Nippon To Co-Develop THCR .....II-41
AAIPharma Acquires Pain Products .....II-41
PainCare & Spine & Pain Center in a Definitive Merger Agreement .....II-41
Elan and Ingenium in a Strategic Alliance .....II-41
1$100
  6. Focus on Select Key Players.....II-423 $300  
   AstraZeneca PLC (UK).....II-42
Eli Lilly and Company (USA).....II-42
Glaxo Smithkline Plc (UK).....II-42
Johnson & Johnson (USA).....II-42
1$100
   Merck & Co., Inc (USA).....II-43
Novartis Pharmaceuticals Corporation (USA).....II-43
Pfizer Inc. (USA).....II-43
Purdue Pharma (USA).....II-43
Sanofi Aventis (France).....II-43
1$100
   Wyeth (USA).....II-44
1$100
  7. Global Market Perspective.....II-45   
   Table 2: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....II-451$300
   Table 3: World* Recent Past, Current & Future Analysis for Pain Management by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-461$300
   Table 4: World Historic Review for Pain Management by Geographic Region – US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....II-471$300
   Table 5: World 20-Year Perspective for Pain Management by Geographic Region – Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....II-481$300
   Table 6: World Recent Past, Current & Future Analysis for Pain Management Pharmaceuticals by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....II-491$300
   Table 7: World* Recent Past, Current & Future Analysis for Pain Management Pharmaceuticals by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-501$300
   Table 8: World Historic Review for Pain Management Pharmaceuticals by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....II-511$300
   Table 9: World 20-Year Perspective for Pain Management Pharmaceuticals by Geographic Region – Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....II-521$300
   Table 10: World Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....II-531$300
   Table 11: World* Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-541$300
   Table 12: World Historic Review for Pain Management Devices by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....II-551$300
   Table 13: World 20-Year Perspective for Pain Management Devices by Geographic Region – Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....II-561$300
   Table 14: World Recent Past, Current & Future Analysis for Pain Management Services by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....II-571$300
   Table 15: World Long-Term Projections for Pain Management Services by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-581$300
   Table 16: World Historic Review for Pain Management Services by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....II-591$300
   Table 17: World 20-Year Perspective for Pain Management Services by Geographic Region – Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....II-601$300
III. MARKET61$1950
  1. The United States.....III-116 $1200  
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Pain Statistics in the US.....III-1
1$75
   Industry Overview.....III-2
Measures to Thwart Drug Abuse.....III-2
Market for Cancer Pain Therapeutics.....III-2
1$75
   Leading Players/Brands.....III-3
Table 18: Leading Oral Pain Relievers in the US Market for Pain Management (2006) – Percentage Breakdown of Value Sales by Brand for Orajel, Anbesol, Baby Orajel, Colgate Peroxyl, Zilactin, Glyoxide, Hyland's, Dentek Temparin, Orajel Mouth Aid, and Others (includes corresponding Graph/Chart).....III-3

Table 19: Leading OTC Pain Relievers in the US Market for Pain Management (2006) – Percentage Breakdown of Value Sales by Brand for Advil, Tylenol, Aleve, Bayer, Tylenol PM, Motrin IB, Excedrin, Tylenol Arthritis, Excedrin Migraine, Private label, and Others (includes corresponding Graph/Chart).....III-3
1$150
   Product Launches.....III-43$225
   Strategic Corporate Developments.....III-76$450
   Key Players.....III-13
Eli Lilly and Company.....III-13
Johnson & Johnson.....III-13
Merck & Co., Inc......III-13
Novartis Pharmaceuticals Corporation.....III-13
1$75
   Pfizer, Inc......III-14
Purdue Pharma.....III-14
Wyeth.....III-14
1$75
   B. Market Analytics.....III-15
Table 20: US Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-15

Table 21: US Long-Term Projections for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-15
1$150
   Table 22: US Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-16

Table 23: US 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (Includes corresponding graphs/chart).....III-16
1$150
  2. Canada.....III-173 $325  
   Market Analysis.....III-17
Table 24: Canadian Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-17
1$150
   Table 25: Canadian Long-Term Projections for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-18

Table 26: Canadian Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-18
1$150
   Table 27: Canadian 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-19
1$150
  3. Japan.....III-203 $225  
   A. Market Analysis.....III-20
Current & Future Analysis.....III-20
Strategic Corporate Developments.....III-20
1$75
   B. Market Analytics.....III-21
Table 28: Japanese Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-21

Table 29: Japanese Long-Term Projections for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-21
1$150
   Table 30: Japanese Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-22

Table 31: Japanese 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-22
1$150
  4. Europe.....III-236 $575  
   A. Market Analysis.....III-23
Current & Future Analysis.....III-23
Strategic Corporate Developments.....III-23
1$75
   B. Market Analytics.....III-24
Table 32: European Recent Past, Current & Future Analysis for Pain Management by Geographic Region – France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-24
1$150
   Table 33: European Long-Term Projections for Pain Management by Geographic Region – France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-25

Table 34: European Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-25
1$150
   Table 35: European Long-Term Projections s for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-26

Table 36: European Historic Review for Pain Management by Geographic Region – France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-26
1$150
   Table 37: European Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices And Pain Management Services Markets Independently Analyzed With Annual Revenue Figures in US$ Million For Years 1991 through 2000 (includes corresponding Graph/Chart).....III-27

Table 38: European 20-Year Perspective for Pain Management by Geographic Region – Percentage Breakdown of Dollar Revenue for France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-27
1$150
   Table 39: European 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-28
1$150
  4a. France.....III-293 $225  
   A. Market Analysis.....III-29
Strategic Corporate Developments.....III-29
Key Player Review.....III-29
Sanofi Aventis.....III-29
1$75
   B. Market Analytics.....III-30
Table 40: French Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-30

Table 41: French Long-Term Projections for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-30
1$150
   Table 42: French Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-31

Table 43: French 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-31
1$150
  4b. Germany.....III-323 $325  
   Market Analysis.....III-32
Table 44: German Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-32
1$150
   Table 45: German Long-Term Projections for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-33

Table 46: German Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-33
1$150
   Table 47: German 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-34
1$150
  4c. United Kingdom.....III-354 $375  
   A. Market Analysis.....III-35
UK Pain Statistics.....III-35
Key Player Review.....III-35
Glaxo Smithkline Plc.....III-35
1$75
   AstraZeneca Plc.....III-36
B. Market Analytics.....III-36
Table 48: UK Recent Past, Current & Future Analysis for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-36
1$150
   Table 49: UK Long-Term Projections for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-37

Table 50: UK Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-37
1$150
   Table 51: UK 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-38
1$150
  4d. Italy.....III-393 $325  
   Market Analysis.....III-39
Table 52: Italian Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-39
1$150
   Table 53: Italian Long-Term Projections for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-40

Table 54: Italian Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-40
1$150
   Table 55: Italian 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-41
1$150
  4e. Spain.....III-423 $325  
   Market Analysis.....III-42
Table 56: Spanish Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-42
1$150
   Table 57: Spanish Long-Term Projections for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-43

Table 58: Spanish Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-43
1$150
   Table 59: Spanish 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-44
1$150
  4f. Russia.....III-453 $325  
   Market Analysis.....III-45
Table 60: Russian Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-45
1$150
   Table 61: Russian Long-Term Projections for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-46

Table 62: Russian Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-46
1$150
   Table 63: Russian 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-47
1$150
  4g. Rest of Europe.....III-484 $375  
   A. Market Analysis.....III-48
Strategic Corporate Development.....III-48
1$75
   B. Market Analytics.....III-49
Table 64: Rest of Europe Recent Past, Current & Future Analysis for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-49
1$150
   Table 65: Rest of Europe Long-Term Projections for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-50

Table 66: Rest of Europe Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-50
1$150
   Table 67: Rest of Europe 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-51
1$150
  5. Asia-Pacific.....III-524 $400  
   A. Market Analysis.....III-52
Current & Future Analysis.....III-52
India.....III-52
Strategic Corporate Developments.....III-52
1$75
   B. Market Analytics.....III-53
Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-53
1$150
   Table 69: Asia-Pacific Long-Term Projections for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-54

Table 70: Asia-Pacific Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-54
1$150
   Table 71: Asia-Pacific 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-55
1$150
  6. Latin America.....III-563 $325  
   Market Analysis.....III-56
Table 72: Latin America Recent Past, Current & Future Analysis for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-56
1$150
   Table 73: Latin America Long-Term Projections for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-57

Table 74: Latin America Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-57
1$150
   Table 75: Latin America 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-58
1$150
  7. Rest of World.....III-593 $450  
   Market Analysis.....III-59
Table 76: Rest of World Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-59
1$150
   Table 77: Rest of World Long-Term Projections s for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-60

Table 78: Rest of World Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-60
1$150
   Table 79: Rest of World 20-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart).....III-611$150
IV. COMPETITIVE LANDSCAPE 184$995
  
Total Companies Profiled: 118 (including Divisions/Subsidiaries - 130)

Region/Country                 Players

The United States                    80
Canada                                4
Japan                                 5
Europe                               32
     France                           4
     Germany                          4
     The United Kingdom              11
     Italy                            2
     Rest of Europe                  11
Asia-Pacific (Excluding Japan)        7
Middle East                           1
Latin America                         1
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.